Preoperative indicators of clinical outcome following stereotaxic pallidotomy

Neurology

Volumn 49, Issue 4, 1997, Pages 1083-1090

  Kazumata, K ^a,d   Antonini, A ^a   Dhawan, V ^a   Moeller, J R ^b   Alterman, R L ^c   Kelly, P ^c   Sterio, D ^c   Fazzini, E ^c   Beric, A ^c   Eidelberg, D ^a  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; BRAIN SURGERY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GLOBUS PALLIDUS; HUMAN; MALE; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; STEREOTAXIC SURGERY; TREATMENT OUTCOME;

EID: 0030709430     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.49.4.1083     Document Type: Article

References (35)

1. Laitinen LV, Bergenheim AT, Hariz MI. Leksell's posterolateral ventral pallidotomy in the treatment of Parkinson's disease. J Neurosurg 1992;76:53-61.
2. Dogali M, Fazzini E, Kolodny E, et al. Stereotactic ventral pallidotomy for Parkinson's disease. Neurology 1995;45:753-761.
3. Lozano AM, Lang AE, Galvez-Jiminez N, et al. Effects of GPi pallidotomy on motor function in Parkinson's disease. Lancet 1995;346:1383-1387.
4. Baron MS, Vitek JL, Bakey RAE, et al. Treatment of advanced Parkinson's disease by internal globus pallidotomy: 1-year results of a pilot study. Ann Neurol 1996;40:355-366.
5. Alexander GE, Crutcher MD, DeLong MR. Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions [Review]. Prog Brain Res 1990;85:119-146.
6. Bergman H, Wichmann T, Karmon B, DeLong MR. The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of Parkinsonism. J Neurophysiol 1994;72:507-520.
7. Palombo E, Porrino LJ, Bankiewicz KS, et al. Local cerebral glucose utilization in monkeys with hemiparkinsonism induced by intracarotid infusion of the neurotoxin MPTP. J Neurosci 1990;10:860-869.
8. Crossman AR. A hypothesis on the pathophysiological mechanisms that underlie levodopa- or dopamine agonist-induced dyskinesia in Parkinson's disease: implications for future strategies in treatment. Mov Disord 1990;5:100-108.
9. 18F]fluorodopa positron emission tomography studies. Mov Disord 1990;5:203-213.
10. Eidelberg D, Moeller JR, Dhawan V, et al. The metabolic topography of parkinsonism. J Cereb Blood Flow Metab 1994; 14:783-801.
11. 18F-fluorodeoxyglucose and PET. J Nucl Med 1995;36:378-383.
12. 18F-fluorodeoxyglucose and positron emission tomography. Neurology 1995;45:1995-2004.
13. Ceballos-Baumann AO, Obeso JA, Vitek JL. Restoration of thalamocortical activity after posteroventral pallidotomy in Parkinson's disease. Lancet 1994;344:814.
14. Grafton ST, Waters C, Sutton J, Lew MF, Couldwell W. Pallidotomy increases activity of motor association cortex in Parkinson's disease: a positron emission tomographic study. Ann Neurol 1995;37:776-783.
15. Eidelberg D, Moeller JR, Ishikawa T, et al. Regional metabolic correlates of surgical outcome following unilateral pallidotomy for Parkinson's disease. Ann Neurol 1996;39:450-459.
16. Dogali M, Beric A, Sterio D, et al. Anatomic and physiologic considerations in pallidotomy for Parkinson's disease. Stereotact Funct Neurosurg 1994;62:53-60.
17. Langston JW, Widner H, Goetz CG, et al. Core assessment program for intracerebral transplantations (CAPIT). Mov Disord 1992;7:2-13.
18. Mugler JP, Brookeman JR. Three-dimensional magnetization-prepared rapid gradient-echo imaging (3D MP RAGE) Magn Reson Med 1990;15:152-157.
19. Tomlinson FH, Clifford RJ, Kelley PJ. Sequential magnetic resonance imaging following stereotactic radiofrequency vetralis lateralis thalamotomy. J Neurosurg 1991;74:579-584.
20. DeGrado TR, Turkington TG, Williams JJ, et al. Performance characteristics of a whole-body PET scanner. J Nucl Med 1994;35:1398-1406.
21. Hariz MI. Clinical study on the accuracy of the Laitinen CT-guidance system in functional stereotactic neurosurgery. Stereotact Funct Neurosurg 1991;56:109-128.
22. 18F-2-fluoro-2-deoxy-D-glucose. Validation of method. Ann Neurol 1979;6:371-388.
23. Takikawa S, Dhawan V, Robeson W, et al. Noninvasive quantitative FDG-PET studies using an estimated input function derived from a population arterial blood curve. Radiology 1993;188:131-136.
24. Spetsieris P, Dhawan V, Takikawa S, et al. Imaging cerebral function. IEEE/Comput Graphics 1993;13:15-26.
25. Sterio D, Beric A, Dogali M, Fazzini E, Alfaro G, Devinsky O. Neurophysiological properties of pallidal neurons in Parkinson's disease. Ann Neurol 1994;35:586-591.
26. Schaltenbrand G, Wahren W. Atlas for stereotaxy of the human brain. Stuttgart: Thieme, 1977.
27. 14C]deoxyglucose labeling in optic tectum of the rattlesnake. J Neurophysiol 1983;49:1504-1516.
28. Sokoloff L. Relationship between functional activity and energy metabolism in the nervous system: whether, where and why? In: Lassen NA, Ingvar DH, Raichle ME, Friberg L, eds. Brain work and mental activity. Copenhagen: Munksgaard, 1991:52-64.
29. Eidelberg D, Moeller JR, Kazumata K, et al. Metabolic correlates of pallidal neuronal activity in Parkinson's Disease. Brain 1997 (in press).
30. Blesa R, Blin J, Miletich R, et al. Levodopa-reduced glucose metabolism in striato-pallidothalamo-cortical circuit after posteroventral pallidotomy in Parkinson's disease. Neurology 1991(suppl 1):41:359.
31. Eidelberg D, Moeller JR, Ishikawa T, et al. The metabolic topography of idiopathic torsion dystonia. Brain 1995;118: 1473-1484.
32. Farve J, Taha JM, Ngugen TT, Gildenberg PL, Burchiel KJ. Pallidotomy: a survey of current practice in North America. Neurosurgery 1996;39:883-892.
33. Lozano AM, Hutchinson W, Kiss Z, et al. Methods for microelectrode-guided posteroventral pallidotomy. J Neurosurg 1996;84:194-202.
34. Olanow CW, Good PF, Shinotoh H, et al. Manganese intoxication in the rhesus monkey: a clinical, imaging, pathologic, and biochemical study. Neurology 1996;46:492-498.
35. Eidelberg D, Takikawa S, Moeller JR, et al. Striatal hypometabolism distinguishes striatonigral degeneration from Parkinson's disease. Ann Neurol 1993;33:518-527.